MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative

Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen (Miami, USA)

Meeting: 2022 International Congress

Abstract Number: 1476

Keywords: Depression

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: Assess the feasibility of systematic depression screening of people with Parkinson’s (PWP) and determine barriers in the specialist movement disorders setting.

Background: While depression is commonly experienced among PWP, depression screening practices for the majority of PWP are inconsistent. Within Parkinson’s Foundation Centers of Excellence (PF COE), a substantial proportion of PWP (> 50%) with identifiable symptoms of depressed mood are not receiving pharmacologic intervention or mental health services.  Systematic depression screening could not only identify untreated depression in PWP but also allows monitoring of treatment response, ultimately improving quality of life.

Method: Systematic depression screening of PWP attending appointments for follow-up care is being implemented at 5 PF COE sites using the 15-item Geriatric Depression Scale (GDS-15). To understand pre-existing depression screening practices, diagnosis and treatment practices, 10 patient medical records per clinician at each site will be reviewed. Qualitative interviews with clinicians and PWP will be conducted to understand feasibility and barriers to implementation. Depression-specific educational resources and a treatment algorithm are being provided to the health care team. Up to 130 PWP who screen positive for depression (GDS-15 > 4) will be invited to a prospective study of 12 months that will collect PDQ-39, GDS-15 and depression treatment data.

Results: Primary outcome measures are the proportion of PWP that complete the GDS-15 at clinical visits and the feasibility of incorporating systematic screening into routine care. Secondary outcome measures include: 1) the difference in the proportion of PWP screened for depression in the one-year period before and during the study period; 2) the proportion of responders to depression care among those screening positive , where a reduction in GDS-15 score of 50% between baseline and 12 months is considered a response; and 3) the change in PDQ-39 emotional subscales between baseline and the follow-up visits up to 12-months among those screening positive for depression.

Conclusion: Implementation of systematic depression screening in PWP will improve the standard of care for PD by raising awareness among both clinicians and PWP and by providing treatment decision aides to improve quality of life.

GDS SHORT FORM

To cite this abstract in AMA style:

Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen. Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/screening-and-treatment-of-depression-in-parkinsons-disease-within-movement-disorders-centers-a-quality-improvement-initiative/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/screening-and-treatment-of-depression-in-parkinsons-disease-within-movement-disorders-centers-a-quality-improvement-initiative/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley